Go to content | Go to main menu | Go to search
LINET Group, the world's number one advanced care bed manufacturer, invests substantial funds into its research & development activities to bring innovative solutions to the market. It is also prepared to heavily defend all its investments worldwide. LINET Group owns approximately 50 patents, 30 industrial models and 100 registered trademarks.
Last year, a project of LINET and University of Hradec Králové became the winner in one of four main categories of the Technology Agency of the Czech Republic Awards, which annually awards the best applied research projects. Last year's absolute winner was the project “COVID-19 Infodemic: AI communication platform suppressing the infodemic.” Its main researcher, Václav Moravec, dedicated the Czech Idea statuette to the winners of all categories of the TA CR 2022 Awards.
Strengthening its presence in the Australian market to offer its full range of premium services to the customer in New South Wales is the main reason for the acquisition of Sydney-based Pegasus Health Group.
We would like to proudly announce the launch of our premium Emergency and transportation stretcher “Sprint 200”. It is a part of the new generation of stretchers taking patient transportation and patient care to the next level with its innovative solutions.
In autumn 2021, we introduced the Multicare X bed with Opticare X mattress, a brand-new premium solution dedicated to intensive care units. Shortly after its introduction, the product’s innovative design has been acknowledged with the renowned Good Design® Award.
"Russia's aggression against sovereign Ukraine is completely unacceptable to us. It is unbelievable what we are now witnessing. As Czechs, we perceive it very personally. LINET will help Ukraine, our Ukrainian employees and their families," says Tomáš Kolář, Managing Director LINET Group.
